top of page

Improving Personalized Care for Heart Failure & At-Risk Patients

"Point & Press"
Hemodynamic Monitoring

Rapid, accurate and objective, non-invasive hemodynamic insights for heart failure and at-risk patients across the entire continuum of care with an easy-to-use, camera-based solution.

With VenoVision on hand, medical teams can make more-informed decisions to:

Reduce Invasive
& ICU Monitoring

Improve Patient
Trajectory

Keep Patients

Home with RPM

Discharge Safely
& More Stable

VenoVision VVC-100 Detects Central Venous Pressure.png

Central Venous Pressure & Waveform Pattern

VenoVision harnesses the power of thermal imaging & machine learning to deliver central venous pressure and its waveform pattern, uniquely overcoming the challenges of assessing obese patients.

With VenoVision, healthcare teams will be better able to spot deterioration sooner and guide therapy more closely, helping to drive down the billions of dollars currently lost on avoidable ICU days, excess lengths of stays, & (re)hospitalizations.

Why Specialists Want  To Use VenoVision

Workflow Integration

Vitals from the guidelines, not a new scale or correlation to learn.

Easy-to-Use

No need for specialist operators, placement of patches or ICU admission.

Rapid & Safe

Avoids waiting hours for a skilled echocardiologist or catheterization.

Precise & Objective

Overcomes the limitations of traditional visual CVP estimation.

Accessible & Equitable

Irrespective of obesity or skin color, clinical or home setting, rural health, or user.

Health Wildcatters.jpg

2022 Accelerator
Portfolio Company

Achievements

M2D2 Impact Logo.png

M2D2 Impact 2023

"Most Innovative Award"

VenoVision - MassChallenge Alumni.png

2021

Israel

MATTER-Logo.png

Matter Incubator
2023 Member

ICI Meeting.png

Proof-of-Concept
Clinical Trial Presented at
The ICI Meeting

Canada-Israel Innovation Forum logo.png

Canada-Israel Cardiovascular Innovation Forum 2022 Finalist

Boston Scientific.png

Boston Scientific Connected Patient Challenge VII
2023 Finalist

Become a VenoVisioneer

Thanks for reaching out to us!

VenoVision VVC-100 is not an FDA-approved medical device.
VenoVision Inc. is a Delaware C-Corp. It was conceptualized in the BioDesign Israel program at the Hebrew University of Jerusalem, in collaboration with Shaare Zedek Medical Center & Hadassah Medical Center.

©2018 by VenoVision. Proudly created with Wix.com

bottom of page